Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze AGIO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate AGIO investment potential.

What is AGIO stock price today?

Get real-time AGIO stock price, historical data, and price charts on Financhill. Track AGIO performance with our advanced analysis tools.

Is AGIO a good investment?

Evaluate AGIO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy AGIO stock?

To buy AGIO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of AGIO?

View detailed market capitalization data and company valuation metrics for AGIO on our comprehensive analysis page.

What is the P/E ratio of AGIO?

Use our fundamental analysis tools to view AGIO P/E ratio and compare valuation metrics with industry peers.

What are AGIO earnings?

View AGIO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Agios Pharmaceuticals, Inc. 10K Form

Sell

AGIO
Agios Pharmaceuticals, Inc.

Last Price:

$30.24

Seasonality Move:

0.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-02	10Q	AGIO/Agios Pharmaceuticals, Inc. Quarterly
2023-11-02	10Q	AGIO/Agios Pharmaceuticals, Inc. Quarterly
2023-08-03	10Q	AGIO/Agios Pharmaceuticals, Inc. Quarterly
2023-05-04	10Q	AGIO/Agios Pharmaceuticals, Inc. Quarterly
2022-11-03	10Q	AGIO/Agios Pharmaceuticals, Inc. Quarterly
2022-08-04	10Q	AGIO/Agios Pharmaceuticals, Inc. Quarterly

Receive AGIO News And Ratings

See the #1 stock for the next 7 days that we like better than AGIO

AGIO Financial Statistics

Sales & Book Value

Annual Sales:	$54M
Cash Flow:	$-97.3M
Price / Cash Flow:	0
Annual Sales:	$20.41
Price / Book:	1.48

Profitability

EPS (TTM):	-7.11890
Net Income (TTM):	$-412.8M
Gross Margin:	$42.5M
Return on Equity:	-30.11%
Return on Assets:	-27.99%

Agios Pharmaceuticals, Inc. Earnings Forecast

Key Agios Pharmaceuticals, Inc. Financial Ratios

The Gross Profit Margin over the past 13 years for AGIO is 78.67%.
The Selling, General & Administrative Expenses for AGIO have been equal to 333.68% of Gross Profit Margin.
The Research & Development expenses have been 618.86% of Revenue.
The Net Earning history of AGIO is -764.01% of Total Revenues.
Per Share Earnings over the last 15 years have been positive in 5 years.

Agios Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	AGIO
CUSIP:	00847X
Website:	agios.com

Debt

Debt-to-Equity Ratio:	0.03
Current Ratio:	11.46
Quick Ratio:	10.52

Price-to-Earnings

Trailing P/E Ratio:	2.41
Forward P/E Ratio:	2.01

AGIO Technical Analysis vs Fundamental Analysis